Since an epigenetic regulation of PTPRE via promotor methylation has been described for pituitary adenomas and papillary thyroid carcinoma [15,16], we performed PTPRE promotor methylation analyses for the etoposide-resistant RB cell lines Y79 and WERI and their chemosensitive counterparts. This evidence concerns the gene PTPRE and differentiated thyroid carcinoma.